Andy Li | CEO
BioSense |

Andy Li, CEO, BioSense

Andy has more than 25 years of biomedical research and biopharmaceutical industry experience with proven track records in global drug development in multiple therapeutic areas, alliance management, and business development. He previously held management positions at GSK, Abbott and most recently, Daiichi Sankyo. During his extensive career, Andy worked directly on highly successful projects and products, including HUMIRA and Olmesartan. He also managed and led the development, registration, and commercialization efforts in key markets, including the U.S., Europe, Japan, China, Korea, Taiwan, Brazil and others.

PhD from Albert Einstein College of Medicine and MBA from Duke University.


Phar East 2020 Agenda Day One @ 10:00

Keynote Panel: Creating a collaborative drug development ecosystem

last published: 09/Dec/20 03:45 GMT

back to speakers






For speaking, sponsorship and exhibition opportunities contact
Tel: +65 6322 2738